Faes Farma, S.A. (BME:FAE)
5.17
-0.05 (-0.96%)
Feb 6, 2026, 4:01 PM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.62 billion as of February 6, 2026. Its market cap has increased by 49.58% in one year.
Market Cap
1.62B
Enterprise Value
1.60B
Revenue
571.12M
Ranking
n/a
PE Ratio
15.48
Stock Price
€5.17
Market Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.62B, an increase of 893.18%. That is a compound annual growth rate of 7.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 1.63B | 1.55% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.69B |
| Laboratorios Farmaceuticos Rovi | 3.73B |
| Almirall | 2.76B |
| Pharma Mar | 1.34B |
| Clínica Baviera | 842.24M |
| Oryzon Genomics | 253.51M |
| Atrys Health | 226.86M |
| Laboratorio Reig Jofre | 224.64M |